Area of research
Hematology · Public Health, Environmental and Occupational Health
Research interest
Research interests include Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research, and Chronic Myeloid Leukemia Treatments.
Long-Term Follow-Up of the Baltimore Experience with Hematopoietic Cell Transplantation for Severe Aplastic Anemia Using Post-Transplantation Cyclophosphamide
Measurable residual disease and posttransplantation gilteritinib maintenance for patients with <i>FLT3-ITD</i>–mutated AML
Impact of posttransplant cyclophosphamide-based GVHD prophylaxis in patients 70 years and older: an update from BMT CTN 1703
Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703
Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of <i>FLT3</i>
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis
Haploidentical donor hematopoietic cell transplantation for myelodysplastic/myeloproliferative overlap neoplasms: results from a North American collaboration
Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil As the New Standard for Graft-Versus-Host Disease (GVHD) Prophylaxis in Reduced Intensity Conditioning: Results from Phase III BMT CTN 1703
Outcome of donor-derived TAA-T cell therapy in patients with high-risk or relapsed acute leukemia post allogeneic BMT
The role of the atypical chemokine receptor CCRL2 in myelodysplastic syndrome and secondary acute myeloid leukemia.
Signatures of GVHD and relapse after posttransplant cyclophosphamide revealed by immune profiling and machine learning
Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial
Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide
Allogeneic bone marrow transplantation with post-transplant cyclophosphamide for patients with HIV and haematological malignancies: a feasibility study
Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203)
Effect of increased dose of total body irradiation on graft failure associated with HLA-haploidentical transplantation in patients with severe haemoglobinopathies: a prospective clinical trial
Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide
Alternative Donor Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Refractory Severe Aplastic Anemia
Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide
A Refined Risk Score for Acute Graft-versus-Host Disease that Predicts Response to Initial Therapy, Survival, and Transplant-Related Mortality
Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults
Adoptive transfer of activated marrow-infiltrating lymphocytes induces measurable antitumor immunity in the bone marrow in multiple myeloma
Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS
Aldehyde Dehydrogenase Expression Drives Human Regulatory T Cell Resistance to Posttransplantation Cyclophosphamide
Regulation of human hematopoietic stem cell self-renewal by the microenvironment’s control of retinoic acid signaling
Partially Mismatched Transplantation and Human Leukocyte Antigen Donor-Specific Antibodies
HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease
A clinically relevant population of leukemic CD34+CD38− cells in acute myeloid leukemia
HIV-1 DNA Is Detected in Bone Marrow Populations Containing CD4+ T Cells but Is not Found in Purified CD34+ Hematopoietic Progenitor Cells in Most Patients on Antiretroviral Therapy
Nuclear Physics Research and Education with GlueX
Research and Education with GlueX
CC* Compute: Shared Computing Infrastructure for Large-scale Science Problems
Research and Education with GlueX
Research and Education with GlueX
Research and Education with GlueX
Nuclear Physics Research and Education with GlueX
US-Japan Nuclear Physics Workshop
Collaborative Research: Open Access Amplitude Analysis on a Grid
Research Program in Intermediate Energy Physics
Research Program in Intermediate Energy Physics
Co-editor of "NSF Highlights" Column Published in The Journal of Chemical Education
Research Program in Experimental Intermediate Energy Physics
Co-editor of "NSF Highlights" Column in The Journal of Chemical Education
Instrumentation Workshop for Two-Year College Chemistry Faculty
Instrumentation Workshop for Two-Year College Chemistry Faculty
Neuroendocrine Control of Brain Aging
1996 Presidential Awardee
Dissertation Research: The Effects of Cortisol on Home- Steam Water Imprinting and Recall in Kokanee Salmon
Instrumentation Workshops for Two-Year College Chemistry Faculty
Instrumentation Workshops for Two-Year College Chemistry Faculty
New Directions in Metal Phosphido and Arsenido Chemistry
Introduction of NMR into Organic Chemistry Laboratories
Bilateral NSF-SERC Main Group Chemistry Workshop, Imperial College, London, England, August 9-12, 1989
The Role of U.S. Migration in the Economic Base of Rural Mexico